Search research articles
Contact Us
Filters
Showing results (41-50 of 139) with videos related to
Page
of 14
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
December 19, 2016
The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials
Bob T Li, Tristan A Barnes, David L Chan, et al.
JCO Precision Oncology
|
September 14, 2020
Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine
Sebastian Mondaca, Pedram Razavi, Chongrui Xu, et al.
Plos One
|
January 6, 2016
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers
Bob T Li, Emil Lou, Meier Hsu, et al.
Asia-Pacific Journal of Clinical Oncology
|
September 30, 2017
Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer
Aaron C Tan, Bob T Li, Kazi Nahar, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 28, 2021
Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib
Joshua M Bauml, Bob T Li, Vamsidhar Velcheti, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
August 8, 2015
Measurement of preoperative lobar lung function with computed tomography ventilation imaging: progress towards rapid stratification of lung cancer lobectomy patients with abnormal lung function
Enid M Eslick, Dale L Bailey, Benjamin Harris, et al.
Translational Lung Cancer Research
|
September 12, 2022
Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer
Justin M Haseltine, Michael Offin, Jessica R Flynn, et al.
Cancer Treatment Reviews
|
April 17, 2022
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management
Sandra M Swain, Mizuki Nishino, Lisa H Lancaster, et al.
The Oncologist
|
August 24, 2023
Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers
Naryan Rustgi, Ann Maria, Nicolas Toumbacaris, et al.
JCO Precision Oncology
|
June 29, 2023
Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced <i>KRAS G12C</i>-Mutant Non-Small Cell Lung Cancer
Rohit Thummalapalli, Ezra Bernstein, Benjamin Herzberg, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 139) with videos related to
Sort By:
Page
of 14
Lung Cancer (Amsterdam, Netherlands)
|
December 19, 2016
The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials
Bob T Li, Tristan A Barnes, David L Chan, et al.
JCO Precision Oncology
|
September 14, 2020
Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine
Sebastian Mondaca, Pedram Razavi, Chongrui Xu, et al.
Plos One
|
January 6, 2016
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers
Bob T Li, Emil Lou, Meier Hsu, et al.
Asia-Pacific Journal of Clinical Oncology
|
September 30, 2017
Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer
Aaron C Tan, Bob T Li, Kazi Nahar, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 28, 2021
Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib
Joshua M Bauml, Bob T Li, Vamsidhar Velcheti, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
August 8, 2015
Measurement of preoperative lobar lung function with computed tomography ventilation imaging: progress towards rapid stratification of lung cancer lobectomy patients with abnormal lung function
Enid M Eslick, Dale L Bailey, Benjamin Harris, et al.
Translational Lung Cancer Research
|
September 12, 2022
Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer
Justin M Haseltine, Michael Offin, Jessica R Flynn, et al.
Cancer Treatment Reviews
|
April 17, 2022
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management
Sandra M Swain, Mizuki Nishino, Lisa H Lancaster, et al.
The Oncologist
|
August 24, 2023
Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers
Naryan Rustgi, Ann Maria, Nicolas Toumbacaris, et al.
JCO Precision Oncology
|
June 29, 2023
Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced <i>KRAS G12C</i>-Mutant Non-Small Cell Lung Cancer
Rohit Thummalapalli, Ezra Bernstein, Benjamin Herzberg, et al.
Page
of 14